We’re looking forward to engaging with industry leaders in person at RISE, March 6–8, 2023, in Denver, CO.
Regulatory Review for 2023
Our experts will be available to discuss priority topics, such as:
Impacts of the RADV Final Rule: The Centers for Medicare & Medicaid Services (CMS) released the final MA risk-adjustment data validation (RADV) rule on January 30. The final rule sets future RADV policy and creates uncertainty for MA plans. Avalere is well positioned to provide industry perspectives on the final rule and to help plans mitigate risks posed by RADV audits and operational challenges posed by the rule.
Advance Notice Policies: On February 1, CMS released the 2024 MA and Part D Advance Notice. Plans are required to submit comments by March 6, 2023. The proposed changes have major implications to MA plan payment and long-term strategy. Our policy and health plan operations experts support clients in navigating these policy changes to maximize quality and reimbursement in MA and Part D.
Inflation Reduction Act (IRA) Implications: Avalere’s experts can help clients understand how implementation of the IRA is impacting payment rates, plan bids, and beneficiary out-of-pocket costs, and forecast the likely impact on formulary negotiations.
The Avalere experts below will attend RISE this year. Connect with us to schedule a meeting and see how Avalere can help your business.
Read Our Take on Top Trends
Due to changes proposed in the CY 2024 Advance Notice, enrollees in Medicare Advantage could have hi...
We partner with and support clients in their healthcare transformation efforts to change policies, realign processes, and introduce innovations to improve the way healthcare is delivered.
Health Economics and Outcomes Research
With access to comprehensive real-world data (RWD), our award-winning data and statistics experts develop real-world evidence (RWE), supporting data-driven decision making and market differentiation.
Federal and State Healthcare Policy Consulting
We provide clients with multistakeholder perspectives on federal and state healthcare policy to help them navigate the complex legislative and regulatory environment.